KineMed

Kinamed's business model is centered on the development and sale of these specialized medical devices to hospitals and surgical centers, leveraging a global network of distributors. The company is a privately held entity and has not received external funding, growing organically through its sales, which were estimated to be around $14.8 million annually with a revenue per employee of approximately $251,000. This sustained growth is attributed to a focus on creating unique products that address specific clinical needs, a strategy that proved successful in navigating competitive international markets.

The company's product portfolio is segmented into three main areas: orthopedics, neurosurgery, and cardiothoracic surgery. A key orthopedic product is the SuperCable® Iso-Elastic™ Polymer Cerclage system, a polymer-based solution designed to overcome issues associated with traditional wire cables in bone fixation. Another notable product is the CarboJet® CO2 Bone Preparation System, which cleans and prepares bone surfaces to improve cement fixation during orthopedic procedures. For patients with isolated, end-stage patello-femoral disease, Kinamed offers the KineMatch® Patello-Femoral Replacement, a patient-matched unicompartmental joint replacement. In the realm of neurosurgery, the NeuroPro® Rigid Fixation System is provided for cranial bone repair. The company also has offerings in surgical navigation with its NaviPro® systems for hip, knee, and shoulder procedures.